UA94901C2 - Антибактериальные производные пиперидина - Google Patents

Антибактериальные производные пиперидина

Info

Publication number
UA94901C2
UA94901C2 UAA200710264A UAA200710264A UA94901C2 UA 94901 C2 UA94901 C2 UA 94901C2 UA A200710264 A UAA200710264 A UA A200710264A UA A200710264 A UAA200710264 A UA A200710264A UA 94901 C2 UA94901 C2 UA 94901C2
Authority
UA
Ukraine
Prior art keywords
antibacterial
piperidine derivatives
formula
medicaments
infections
Prior art date
Application number
UAA200710264A
Other languages
English (en)
Ukrainian (uk)
Inventor
Грег Басараб
Брайан Денджел
Пол Роберт Флемінг
Майкл Баррі Грейвсток
Олуінка Грін
Шейла Ірен Хаук
Памела Хілл
Кеннет Грегорі Халл
Джордж Маллен
Брайан Шерер
Фей Чжоу
Original Assignee
Астразенека Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=36218455&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA94901(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Астразенека Аб filed Critical Астразенека Аб
Publication of UA94901C2 publication Critical patent/UA94901C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/541—Non-condensed thiazines containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Abstract

Описаны соединения формулы (I) и их фармацевтически приемлемые соли. Также описаны способы их получения, фармацевтические композиции, которые их содержат, их применение как лекарственных средств и их применение для лечения бактериальных инфекций. EMBED ISISServer (I)
UAA200710264A 2005-02-18 2006-02-16 Антибактериальные производные пиперидина UA94901C2 (ru)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US65467005P 2005-02-18 2005-02-18

Publications (1)

Publication Number Publication Date
UA94901C2 true UA94901C2 (ru) 2011-06-25

Family

ID=36218455

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200710264A UA94901C2 (ru) 2005-02-18 2006-02-16 Антибактериальные производные пиперидина

Country Status (22)

Country Link
US (2) US8399489B2 (ru)
EP (1) EP1853586B1 (ru)
JP (4) JP4058106B2 (ru)
KR (2) KR101422432B1 (ru)
CN (1) CN101163693B (ru)
AR (1) AR053683A1 (ru)
AU (1) AU2006215399B2 (ru)
BR (1) BRPI0607756A2 (ru)
CA (1) CA2598423C (ru)
ES (1) ES2430569T3 (ru)
HK (1) HK1114376A1 (ru)
IL (1) IL185306A (ru)
MX (1) MX2007010072A (ru)
NO (1) NO20074703L (ru)
NZ (1) NZ561613A (ru)
RU (1) RU2424240C2 (ru)
SA (1) SA06270020B1 (ru)
TW (1) TWI402263B (ru)
UA (1) UA94901C2 (ru)
UY (1) UY29384A1 (ru)
WO (1) WO2006087543A1 (ru)
ZA (1) ZA200706920B (ru)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200526626A (en) 2003-09-13 2005-08-16 Astrazeneca Ab Chemical compounds
US8399489B2 (en) * 2005-02-18 2013-03-19 Astrazeneca Ab Antibacterial piperdine derivatives
EP1861396A1 (en) * 2005-03-04 2007-12-05 AstraZeneca AB Tricyclic derivatives of azetidine and pyrrole with antibacterial activity
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
WO2008020229A2 (en) * 2006-08-17 2008-02-21 Astrazeneca Ab Antibacterial pyrrolecarboxamides
WO2008020227A2 (en) * 2006-08-17 2008-02-21 Astrazeneca Ab Antibacterial pyrrolecarboxamides
TW200819437A (en) * 2006-08-17 2008-05-01 Astrazeneca Ab Chemical compounds
WO2008084861A1 (ja) 2007-01-12 2008-07-17 Astellas Pharma Inc. 縮合ピリジン化合物
TW200906412A (en) * 2007-06-12 2009-02-16 Astrazeneca Ab Piperidine compounds and uses thereof
AU2008341953B2 (en) * 2007-12-26 2013-05-02 Msd K.K. Sulfonyl substituted 6-membered ring derivative
TWI498115B (zh) * 2007-12-27 2015-09-01 Daiichi Sankyo Co Ltd 咪唑羰基化合物
US20120108565A1 (en) * 2008-07-30 2012-05-03 Lalima Sharma Pyrrole carboxylic acid derivatives as antibacterial agents
US8841305B2 (en) * 2008-10-09 2014-09-23 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Activators of the human pyruvate kinase M2 receptor
TW201026694A (en) * 2008-12-12 2010-07-16 Astrazeneca Ab Compound 468
US8071605B2 (en) 2008-12-12 2011-12-06 Astrazeneca Ab Piperidine compounds for use in the treatment of bacterial infections
WO2010075257A1 (en) * 2008-12-22 2010-07-01 Chemocentryx, Inc. C5ar antagonists
WO2010118063A2 (en) 2009-04-06 2010-10-14 Agios Pharmaceuticals, Inc. Therapeutic compositions and related methods of use
PL2427441T3 (pl) 2009-05-04 2017-06-30 Agios Pharmaceuticals, Inc. Aktywatory PKM2 do stosowania w leczeniu raka
TW201102065A (en) 2009-05-29 2011-01-16 Astrazeneca Ab Heterocyclic urea derivatives and methods of use thereof
PL2448581T3 (pl) 2009-06-29 2017-06-30 Agios Pharmaceuticals, Inc. Kompozycje terapeutyczne i odnośne sposoby ich stosowania
ES2632954T3 (es) 2009-06-29 2017-09-18 Agios Pharmaceuticals, Inc. Derivados de quinolina-8-sulfonamida que tienen una actividad anticancerosa
TW201111380A (en) 2009-08-26 2011-04-01 Astrazeneca Ab Heterocyclic urea derivatives and methods of use thereof
CA2797694A1 (en) 2010-04-29 2011-11-03 The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services Activators of human pyruvate kinase
PL2585064T3 (pl) 2010-06-24 2017-09-29 Chemocentryx, Inc. Antagoniści C5AR
US20130296363A1 (en) 2010-09-01 2013-11-07 Ambit Biosciences Corporation Quinoline and isoquinoline derivatives for use as jak modulators
EP2651898B1 (en) 2010-12-17 2015-12-09 Agios Pharmaceuticals, Inc. Novel n-(4-(azetidine-1-carbonyl)phenyl)-(hetero-)arylsulfonamide derivatives as pyruvate kinase m2 (pmk2) modulators
MX336022B (es) 2010-12-21 2016-01-06 Agios Pharmaceuticals Inc Activadores de pkm2 bicíclicos.
TWI549947B (zh) 2010-12-29 2016-09-21 阿吉歐斯製藥公司 治療化合物及組成物
EP2511263A1 (en) 2011-04-14 2012-10-17 Phenex Pharmaceuticals AG Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORgamma, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases
CN103476823A (zh) 2011-04-18 2013-12-25 默克专利股份有限公司 共轭聚合物
SG194697A1 (en) 2011-05-03 2013-12-30 Agios Pharmaceuticals Inc Pyruvate kinase activators for use in therapy
WO2013084241A1 (en) * 2011-12-09 2013-06-13 Cadila Healthcare Limited Compounds as inhibitors of renin
CN104093715B (zh) * 2012-02-02 2017-04-26 埃科特莱茵药品有限公司 4‑(苯并咪唑‑2‑基)‑噻唑化合物及相关氮杂衍生物
WO2015011099A1 (en) * 2013-07-22 2015-01-29 Actelion Pharmaceuticals Ltd 1-(piperazin-1-yl)-2-([1,2,4]triazol-1-yl)-ethanone derivatives
PL3670522T3 (pl) 2014-07-24 2022-02-21 W.R. Grace & Co. - Conn. Krystaliczna postać chlorku rybozydu nikotynamidu
CN113121415A (zh) 2014-09-29 2021-07-16 凯莫森特里克斯股份有限公司 制备C5aR拮抗剂的方法和中间体
KR102629310B1 (ko) 2015-03-09 2024-01-24 더블유.알. 그레이스 앤드 캄파니-콘. 니코틴아미드 리보사이드의 결정 형태
US11234976B2 (en) 2015-06-11 2022-02-01 Agios Pharmaceuticals, Inc. Methods of using pyruvate kinase activators
CN105067814A (zh) * 2015-07-24 2015-11-18 中国科学院成都生物研究所 解旋酶水解atp活性测定方法
MY184406A (en) 2015-09-30 2021-04-01 Daiichi Sankyo Co Ltd Hydroxyalkyl thiadiazole derivatives
BR112018014222A2 (pt) 2016-01-14 2018-12-11 Chemocentryx, Inc. método de tratamento da glomerulopatia c3
PT3490986T (pt) 2016-07-28 2022-02-01 Idorsia Pharmaceuticals Ltd Moduladores do recetor de piperidina cxcr7
WO2018169092A1 (en) 2017-03-14 2018-09-20 Daiichi Sankyo Company, Limited N-phosphonoxymethyl prodrugs of hydroxyalkyl thiadiazole derivatives
US20210070747A1 (en) 2017-03-24 2021-03-11 Taisho Pharmaceutical Co., Ltd. 2(1h)-quinolinone derivative
WO2019126482A1 (en) 2017-12-22 2019-06-27 Elysium Health, Inc. Crystalline forms of nicotinamide riboside chloride
CN111683945B (zh) 2018-01-26 2023-11-10 爱杜西亚药品有限公司 Cxcr7受体拮抗剂的结晶型
WO2020048949A1 (en) 2018-09-03 2020-03-12 Univerza V Ljubljani New class of dna gyrase and/or topoisomerase iv inhibitors with activity against gram-positive and gram-negative bacteria
EP4263503A1 (en) 2020-12-17 2023-10-25 Univerza V Ljubljani New n-phenylpyrrolamide inhibitors of dna gyrase and topoisomerase iv with antibacterial activity
CN115466246B (zh) * 2021-06-11 2024-02-06 中国医学科学院药物研究所 吡咯酰哌啶胺类化合物及其用途
CN115612309B (zh) * 2022-10-14 2023-07-21 浙江博澳新材料股份有限公司 一种双杂环双酯基偶氮分散染料及其制备方法

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL23847A (en) 1964-08-07 1969-02-27 Merck & Co Inc Benzimidazoles useful as antifungals
US3963480A (en) 1973-04-11 1976-06-15 Sterling Drug Inc. Herbicidal pyrrole-2-carboxamides
US4046775A (en) 1973-04-11 1977-09-06 Sterling Drug Inc. 4,5-Dihalopyrrole-2-carboxamides
US4912109A (en) 1987-02-02 1990-03-27 Boc, Inc. N-heterocyclic-N-(4-piperidinyl) amides and pharmaceutical compositions and methods employing such compounds
US4791112A (en) 1987-02-02 1988-12-13 The Boc Group, Inc. N-heterocyclic-N-(4-piperidyl)amides and pharmaceutical compositions and methods employing such compounds
US5739135A (en) 1993-09-03 1998-04-14 Bristol-Myers Squibb Company Inhibitors of microsomal triglyceride transfer protein and method
FR2766488B1 (fr) 1997-07-23 2000-02-18 Hoechst Marion Roussel Inc Nouveaux derives aromatiques substitues par un ribose, leur procede de preparation et leur application comme medicaments
AU2437900A (en) * 1999-01-20 2000-08-07 Smithkline Beecham Plc Piperidinylquinolines as protein tyrosine kinase inhibitors
US7629360B2 (en) * 1999-05-07 2009-12-08 Celgene Corporation Methods for the treatment of cachexia and graft v. host disease
JP2003104971A (ja) 1999-08-12 2003-04-09 Wakunaga Pharmaceut Co Ltd 新規アニリド誘導体又はその塩及びこれを含有する医薬
EA005680B1 (ru) 2000-01-18 2005-04-28 Вертекс Фармасьютикалз Инкорпорейтед Ингибиторы гиразы и их применение для лечения бактериальной инфекции
EP1251849A1 (en) 2000-01-18 2002-10-30 Vertex Pharmaceuticals Incorporated Gyrase inhibitors and uses thereof
TWI284639B (en) 2000-01-24 2007-08-01 Shionogi & Co A compound having thrombopoietin receptor agonistic effect
PE20020665A1 (es) 2000-06-15 2002-08-14 Pharmacia Corp ACIDO CICLOALQUIL FENIL ALCANOICO COMO ANTAGONISTA DE INTEGRINAS OVß3
US6964966B2 (en) 2001-04-25 2005-11-15 Wockhardt Limited Generation triple-targeting, chiral, broad-spectrum antimicrobial 7-substituted piperidino-quinolone carboxylic acid derivatives, their preparation, compositions and use as medicaments
DOP2002000386A (es) 2001-05-30 2002-12-15 Warner Lambert Co Agentes antibacterianos
MXPA04001253A (es) 2001-08-09 2004-06-03 Ono Pharmaceutical Co Derivados de acidos carboxilicos y agente farmaceutico que comprende los mismos como ingrediente activo.
MXPA04005343A (es) 2001-12-05 2004-09-27 Aventis Pharma Gmbh 4-fenil-tetrahidro-isoquinolinas sustituidas, procedimiento para su preparacion, su uso como medicamento, y medicamento que las contiene.
AR038536A1 (es) 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
WO2003072554A1 (en) 2002-02-28 2003-09-04 Takeda Chemical Industries, Ltd. Azole compounds
AR040336A1 (es) 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
JP2006503837A (ja) * 2002-09-20 2006-02-02 ルピン・リミテッド 新規の抗マイコバクテリア化合物
US7135469B2 (en) 2003-03-18 2006-11-14 Bristol Myers Squibb, Co. Linear chain substituted monocyclic and bicyclic derivatives as factor Xa inhibitors
CA2519794A1 (en) 2003-04-08 2004-10-21 Sumitomo Pharmaceuticals Co., Ltd. Novel carbapenem compounds
DE10316081A1 (de) * 2003-04-08 2004-10-21 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität
SE0302116D0 (sv) 2003-07-21 2003-07-21 Astrazeneca Ab Novel compounds
US7094791B2 (en) * 2003-07-31 2006-08-22 Avalon Pharmaceuticals, Inc. Derivatives of 3-hydroxy-pyrrole-2,4-dicarboxylic acid and uses thereof
TW200526626A (en) * 2003-09-13 2005-08-16 Astrazeneca Ab Chemical compounds
GB0325956D0 (en) 2003-11-06 2003-12-10 Addex Pharmaceuticals Sa Novel compounds
US20050197336A1 (en) 2004-03-08 2005-09-08 Miikana Therapeutics Corporation Inhibitors of histone deacetylase
US7345043B2 (en) 2004-04-01 2008-03-18 Miikana Therapeutics Inhibitors of histone deacetylase
EP1790636A4 (en) 2004-09-17 2009-07-01 Takeda Pharmaceutical PIPERIDINE DERIVATIVES AND THEIR USE
AU2005299837A1 (en) 2004-10-22 2006-05-04 Janssen Pharmaceutica, N.V. Inhibitors of c-fms kinase
CN101084208A (zh) 2004-10-22 2007-12-05 詹森药业有限公司 作为c－fms激酶抑制剂的芳族酰胺
WO2006087544A2 (en) 2005-02-18 2006-08-24 Astrazeneca Ab Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
US20080161306A1 (en) 2005-02-18 2008-07-03 Brian Sherer Pyrrole Derivatives as Dna Gyrase and Topoisomerase Inhibitors
US8399489B2 (en) 2005-02-18 2013-03-19 Astrazeneca Ab Antibacterial piperdine derivatives
JP2008531671A (ja) 2005-03-04 2008-08-14 アストラゼネカ アクチボラグ 化合物
EP1861396A1 (en) 2005-03-04 2007-12-05 AstraZeneca AB Tricyclic derivatives of azetidine and pyrrole with antibacterial activity
US8071065B2 (en) * 2005-03-31 2011-12-06 Touchstone Research Laboratory, Ltd High density carbon foam composite tooling
US20080312211A1 (en) 2005-12-23 2008-12-18 Astrazeneca Ab Antibacterial Pyrrolopyridines, Pyrrolopyrimidines and Pyrroloazepines-154
TW200819437A (en) 2006-08-17 2008-05-01 Astrazeneca Ab Chemical compounds
TW200906412A (en) * 2007-06-12 2009-02-16 Astrazeneca Ab Piperidine compounds and uses thereof
US8071605B2 (en) * 2008-12-12 2011-12-06 Astrazeneca Ab Piperidine compounds for use in the treatment of bacterial infections

Also Published As

Publication number Publication date
ES2430569T3 (es) 2013-11-21
SA06270020B1 (ar) 2010-10-23
IL185306A (en) 2012-05-31
JP2007326882A (ja) 2007-12-20
AR053683A1 (es) 2007-05-16
BRPI0607756A2 (pt) 2010-05-18
TW200640908A (en) 2006-12-01
AU2006215399A1 (en) 2006-08-24
TWI402263B (zh) 2013-07-21
HK1114376A1 (en) 2008-10-31
JP2008024715A (ja) 2008-02-07
CN101163693B (zh) 2013-03-06
CA2598423C (en) 2014-05-27
JP4058106B2 (ja) 2008-03-05
KR20070113233A (ko) 2007-11-28
NZ561613A (en) 2010-12-24
JP2007326883A (ja) 2007-12-20
UY29384A1 (es) 2006-10-02
WO2006087543A1 (en) 2006-08-24
US20100179150A1 (en) 2010-07-15
RU2424240C2 (ru) 2011-07-20
US8399489B2 (en) 2013-03-19
KR20130093174A (ko) 2013-08-21
EP1853586B1 (en) 2013-07-24
IL185306A0 (en) 2008-02-09
AU2006215399B2 (en) 2010-12-09
EP1853586A1 (en) 2007-11-14
KR101422432B1 (ko) 2014-07-22
JP2008500321A (ja) 2008-01-10
CA2598423A1 (en) 2006-08-24
MX2007010072A (es) 2008-01-28
CN101163693A (zh) 2008-04-16
ZA200706920B (en) 2008-06-25
NO20074703L (no) 2007-11-14
WO2006087543A8 (en) 2007-10-18
RU2007134380A (ru) 2009-03-27
US20130150366A1 (en) 2013-06-13

Similar Documents

Publication Publication Date Title
UA94901C2 (ru) Антибактериальные производные пиперидина
MX2009005603A (es) Compuestos de urea policiclicos antibacterianos.
WO2008020227A3 (en) Antibacterial pyrrolecarboxamides
WO2008020229A3 (en) Antibacterial pyrrolecarboxamides
NO20061657L (no) Pyrolderivater med antibakteriell aktivitet
MX2010009163A (es) Derivados heterociclicos de urea y metodos de uso de los mismos-211.
WO2004062601A3 (en) Antibacterial agents
NO20083250L (no) Antibakterielle pyrrolopyridiner, pyrrolopyrimidiner og pyrroloazepiner
WO2006092599A3 (en) Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
TWI327573B (en) 6-11 bicyclic ketolide derivatives
IL165715A0 (en) 2-ureido-6-heteroaryl-3h-benzoimidazole-4-carboxylic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof
MX2009013501A (es) Compuestos piperidinicos y sus usos.
MY139302A (en) Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
WO2006087544A8 (en) Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
MX2010013310A (es) Derivados de heterociclil urea para el tratamiento de infecciones bacterianas.
TW200639156A (en) New compounds
TW200634021A (en) 3,6-bicyclolides
WO2006087548A3 (en) Pyrrole derivatives as dna gyrase and topoisomerase inhibitors
UA86776C2 (ru) Производные бензимидазола, фармацевтическая композиция, которая их содержит, способ их получения и применение
WO2006039263A3 (en) NOVEL BICYCLIC 9a-AZALIDE DERIVATIVES
TW200504029A (en) Benzimidazole derivatives, compositions containing them, preparation thereof and uses thereof
MX2009006325A (es) Compuestos de heteroaril-heteroarilo como inhibidores de cdk para el tratamiento de cancer, inflamacion e infecciones virales.
GEP20084437B (en) Novel lincomycin derivatives possessing antimicrobial activity
MXPA05013050A (es) Derivados de bencimidazol, composiciones que los contienen preparacion de los mismos y usos de los mismos.
EA200870223A1 (ru) Производные бензоизоиндола для лечения боли